SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001615774-16-006101
Filing Date
2016-06-28
Accepted
2016-06-28 16:36:26
Documents
4
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT s103584_10qa.htm 10-Q/A 33777
2 EXHIBIT 10-2 s103584_ex10-2.htm EX-10.2 148232
3 EXHIBIT 31-1 s103584_ex31-1.htm EX-31.1 10095
4 EXHIBIT 31-2 s103584_ex31-2.htm EX-31.2 10119
  Complete submission text file 0001615774-16-006101.txt   203344
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55415 | Film No.: 161736500
SIC: 2834 Pharmaceutical Preparations